Efek Ekstrak Daun Singawalang (Petiveria alliacea) dalam Menurunkan Kadar Glukosa Darah melalui Peningkatan Ekspresi AMPK-α1 pada Tikus Model Diabetes Melitus
Abstract
Singawalang (Petiveria alliaceae) adalah tumbuhan yang banyak ditemukan di Indonesia dan secara empiris digunakan oleh penduduk untuk mengobati diabetes melitus. Hingga saat ini, penelitian tentang pengaruh dan mekanisme ekstrak daun Singawalang dalam menurunkan kadar glukosa darah belum banyak dilakukan. Tujuan penelitian ini adalah untuk mengetahui pengaruh ekstrak daun Singawalang terhadap penurunan kadar glukosa darah dan ekspresi AMPK-α1 pada hati. Jenis penelitian ini adalah penelitian eksperimental dengan rncangan acak lengkap. Penelitian dilakukan di Laboratorium Farmakologi dan Terapi dan Laboratorium Patologi Anatomi Fakultas Kedokteran Universitas Airlangga pada bulan April–Agustus 2015. Hewan coba tikus strain Rattus norvegicus dibuat model diabetes melitus, diinduksi dengan Streptozotocin. Sebanyak 25 tikus model diabetes melitus dibagi secara acak menjadi 5 kelompok. Kelompok perlakuan 1, 2 dan 3 adalah kelompok yang memperoleh ekstrak daun Singawalang dengan dosis 90 mg/kgbb, 180 mg/kgbb dan 360 mg/kgbb. Kelompok kontrol positif adalah kelompok yang memperoleh metformin dengan dosis 150 mg/kgbb dan kontrol negatif adalah kelompok tikus yang memperoleh vehikulum. Ekstrak dan metformin diberikan sehari sekali, personde selama 14 hari. Pada hari ke-15 setelah terapi, tikus diperiksa kadar glukosa darah dan dieuthanasia untuk diambil organnya. Ekspresi AMPK-α1 dinilai menggunakan imunohistokima. Data yang terkumpul dianalisis dengan ANAVA dan Wilcoxon (α=0,05). Hasil penelitian menunjukkan adanya perbedaan kadar glukosa darah yang bermakna antara kontrol negatif dengan dosis 90 mg/kgbb, dosis 360 mg/kgbb, dan kontrol positif, antara dosis 180 mg/kgbb dengan dosis 360 mg/kgbb dan kontrol positif. Analisis terhadap ekspresi AMPK-α1 pada hati tikus menunjukkan perbedaan yang bermakna antara dosis 180 mg/kgbb dengan dosis 360 mg/kgbb dan kontrol positif. Simpulan dari penelitian ini adalah ekstrak Singawalang dapat menurunkan kadar glukosa darah pada tikus model diabetes melitus melalui aktivasi AMPK-α1.
Kata kunci: AMPK-α1, diabetes melitus, kadar glukosa darah, Singawalang
Effect of Petiveria alliacea Leaves Extract in Decreasing Serum Level of Blood Glucose Level Through Activation of AMPK-α1 in Diabetes Mellitus Rat Models
Abstract
Singawalang (Petiveria alliaceae) is a medicinal herb that is used traditionally as folk medicine for various diseases. The plant has been used as an antidiabetic agent in Indonesian society. Until now, the effect and mechanism of action of Petiveria alliaceae as antidiabetic agent is not clear. The aim of the study was to determine the effect of Petiveria alliaceae to blood glucose level and to identify expression of AMPK-α1 in rat liver. The research was experimental study with randomized and was conducted at Laboratory Pharmacology and Therapy, and Laboratory Patology Anatomy, Faculty of Medicine, Universitas Airlangga, on April until August 2015. Twenty five male rats were injected by Streptozotocin to create diabetic rat models and randomly divided into 5 groups. The group 1, 2 and 3 are treatment groups that were given the ethanol extract of Petiveria alliaceae at dose 90 mg/kgbw, 180 mg/kgbw, and 360 mg/kgbw, orally, once daily for fourteen days. The fourth group is a negative control who were given distilled water and the fifth group is a positive control who were given metformin at dose 150 mg/kgbw. On the 15th day, blood glucose level were measured by glucometer and the rats were sacrificed to collect the liver. Expression of AMPK-α1 were assessed by immunohistochemistry. Data were analyzed by ANAVA and Wilcoxon (α=0,05). The results have been showed that there were significant differences in glucose blood level between negative control with the group were given the extract at dose 90 mg/kgbw, 360 mg/kgbw and positive control, between dose 180 mg/kgbw with dose 360 mg/kgbw and positive control. A significant differences of expression of AMPK-α1 showed between dose 180 mg/kgbw with dose 360 mg/kgbw and positive control. The conclusion of this study was the extract ethanol of Singawalang leaves reduce blood glucose level in diabetes mellitus rat models through increase in the expression of AMPK-α1.
Keywords: AMPK-α1, blood glucose level, diabetes mellitus, Singawalang
Keywords
Full Text:
PDF (Bahasa Indonesia)References
Ozougwu JC, Obimba KC, Belonwu CD, Unakalamba CB. The pathogenesis and pathophysiology of type 1 and type 2 diabetes mellitus. J Physiol Pathophysiol. 2013;4(4):46–57. doi: 10.5897/JPAP2013.0001
World Health Organization. Diabetes mellitus report. 2013.
Departemen Kesehatan Republik Indonesia. Prevalensi Diabetes melitus di Indonesia. Jakarta: Departemen Kesehatan Republik Indonesia; 2010.
Syahbuddin S. Rational therapy for earlier and more aggressive approach in patients with T2DM. Proceeding Cardiometabolic Health Toward 2020. 2010:21–9.
Coughlan KA, Valentine RJ, Ruderman NB, Saha AK. AMPK activation: A therapeutic target for type 2 diabetes? Diabetes Metab Syndr Obes. 2014;7:241–53. doi: 10.2147/DMSO.S43731
Zhang BB, Zhou G, Li C. AMPK: An emerging drug target for diabetes and the metabolic syndrome. Cell Metab. 2009;9(5):407–16. doi: 10.1016/j.cmet.2009.03.012
Moffat C, Harper ME. Metabolic functions of AMPK: Aspects of structure and of natural mutations in the regulatory gamma subunits. IUBMB Life. 2010;62(10):739–45. doi: 10.1002/iub.387
Christie SL, Levy A. Evaluation of the hypoglycaemic activity of Petiveria alliacea (Guinea Hen Weed) extracts in normoglycaemic and diabetic rat models. West Indian Med J. 2013;62(8):685–91. doi: 10.7727/wimj.2013.142.
Christie SLF, Levy ASA. Investigation of hypoglycemic activity of four extracts of Petiveria alliacea (Guinea hen weed) in normoglycemic experimental rat models. FASEB J. 2012;26(1):1124-6.
Zakaria, Mustika A, Ramadhani. Uji toksisitas akut daun singawalang (petiveria alliaceae) pada mencit jantan (mus musculus) (skripsi). Surabaya: Airlangga University; 2010.
Pratiwi IA, Mustika A, Anniwati L. Uji toksisitas jangka pendek ekstrak Singawalang (Petiveria alliacea) terhadap kadar serum transaminase serum (skripsi). Surabaya: Airlangga University; 2013.
Naibaho AH, Mustika A, Rahaju AS. Uji toksisitas jangka pendek ekstrak singawalang (petiveria alliaceae) terhadap nekrosis ginjal mencit (skripsi). Surabaya: Airlangga University; 2013.
Mustika A. Keamanan penggunaan ekstrak etanol petiveria alliacea pada fungsi ginjal mencit. Prosiding Annual Scientific Meeting Universitas Gadjah Mada; Maret 2014; Yogyakarta, Indonesia. Indonesia: Universitas Gadjah Mada; 2014.
King AJ. The use of animal models in diabetes research. Br J Pharmacol. 2012;166(3):877–94. doi: 10.1111/j.1476-5381.2012.01911.x
Lukačínová A, Hubková B, Rácz O, Ništiar F. Animal models for study of diabetes mellitus. InTechOpen. 2013;13. doi: 10.5772/48325
Chatzigeorgiou A, Halapas A, Kalafatakis K, Kamper E. The use of animal models in the study of diabetes mellitus. In Vivo. 2009;23(2):245–58.
Skovso S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. Journal Diabetes Investig. 2014;5(4):349–58. doi: 10.1111/jdi.12235
Dewi MB, Wulandari M, Setyowati DAI, Mustika A, Purwanto B. Curcumin maintains lens protein solubility in streptozotocin induced rat model. Prosiding 22nd International Workshop, Symposium and Seminar of Physiology and Exercise Physiology. Indonesia: Universitas Yarsi; 2013.
Hadad SM, Baker L, Quinlan PR, Robertson KE, Bray SE, Thomson G, et al. Histological evaluation of AMPK signalling in primary breast cancer. BMC Cancer. 2009;9:307. doi: 10.1186/1471-2407-9-307
Quentin T, Kitz J, Steinmetz M, Poppe A, Bär K, Krätzner R. Different expression of the catalytic alpha subunits of the AMP activated protein kinase-an immunohistochemical study in human tissue. Histol Histopathol. 2011;26:589–96.
Trevor AJ, Katzung BG, Hall MK. Pharmacodynamics. In: Katzung. BG, editor. United States: McGraw Hill; 2015
Dandan RH, LBrunton L. Manual of pharmacology and therapeutics. United States: McGraw Hill; 2015.
Aronson JK. Concentration-effect and dose-response relations in clinical pharmacology. British J Clini Pharmacol. 2007;63(3):255–7. doi: 10.1111/j.1365-2125.2007.02871.x
Lagarde F, Beausoleil C, Belcher SM, Belzunces LP, Emond C, Guerbet M, et al. Non-monotonic dose-response relationships and endocrine disruptors: A qualitative method of assessment. Environmen Health. 2015;14(13). doi: 10.1186/1476-069X-14-13
Zoeller R, Brown T, Doan L, Gore A, Skakkebaek N, Soto A, et al. Endocrine-disrupting chemicals and public health protection: A statement of principles from the Endocrine Society. Endocrinology. 2012; 153(9):4097–110. doi: 10.1210/en.2012-1422
Vandenberg LN. Non-monotonic dose responses in studies of endocrine disrupting chemicals: Bisphenol as a case study. Dose Response. 2014;12(2):259–76. doi: 10.2203/dose-response.13-020.Vandenberg
Luz DA, Pinheiro AM, Silva ML, Monteiro MC, Prediger RD, Maia CS, et al. Ethnobotany, phytochemistry and neuropharmacological effects of Petiveria alliacea L.(Phytolaccaceae): A review. J Ethnopharmacology. 2016;185:182–201. doi: 10.1016/j.jep.2016.02.053
Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, David R. Jacobs J, et al. Hormones and endocrine-disrupting chemicals: Low -dose effects and nonmonotonic dose responses. Endocr Rev. 2012;33(3):378–455. doi: 10.1210/er.2011-1050
Kodiha M, Stochaj U. Targeting AMPK for therapeutic intervention in type 2 diabetes. InTechOpen. 2011. doi: 10.5772/20930
DeFronzo RA, Eldor R, Abdul-Ghani M. Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes. Diabetes Care. 2013;36(2):S127–38. doi: 10.2337/dcS13-2011
Ouyang J, Parakhia RA, Ochs RS. Metformin activates AMP kinase through inhibition of AMP deaminase. J Biol Chem. 2011;286(1):1–11. doi: 10.1074/jbc.M110.121806
Jeong KJ, Kim GW, Chung SH. AMP-activated protein kinase: An emerging target for ginseng. J Ginseng Res. 2014;38(2):83–8. doi: 10.1016/j.jgr.2013.11.014.
Xu M, Xiao Y, Yin J, Hou W, Yu X, Shen L, et al. Berberine promotes glucose consumption independently of AMP-activated protein kinase activation. PLoS ONE. 2014;9(7):e103702. doi: 10.1371/journal.pone.0103702.
Hardie DG. AMPK: a target for drugs and natural products with effects on both diabetes and cancer. Diabetes. 2013;62(7):2164–72. doi: 10.2337/db13-0368.
Qiang G, Yang X, Shi L, Zhang H, Chen B, Zhao Y, et al. Antidiabetic effect of salvianolic acid a on diabetic animal models via AMPK activation and mitochondrial regulation. Cell Physiol Biochem. 2015;36(1):395–408. doi: 10.1159/000430258.
DOI: https://doi.org/10.15416/ijcp.2017.6.1.22
Refbacks
- There are currently no refbacks.
Indonesian Journal of Clinical Pharmacy is indexed by